Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats

Nicotine and Tobacco Research

Volumn 10, Issue 6, 2008, Pages 995-1008

  Paterson, Neil ^a   Balfour, David ^b   Markou, Athina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE TARTRATE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SELF ADMINISTRATION; ELECTRODE; ELECTROSTIMULATION; HYPOTHALAMUS; MALE; MOTIVATION; NEUROCHEMISTRY; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SMOKING CESSATION; TASK PERFORMANCE; TOBACCO DEPENDENCE; VEIN CATHETERIZATION; WITHDRAWAL SYNDROME;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; BUPROPION; CONDITIONING (PSYCHOLOGY); DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION; MALE; NICOTINE; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; REWARD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 47349102748     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200802097571     Document Type: Article

References (67)

1. Balfour, D. J. K., Wright, A. E., Benwell, M. E. M. and Birrell, C. E. (2000) The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioral Brain Research, 113, pp. 73-83.
2. Bruijnzeel, A. W. and Markou, A. (2003) Effects of bupropion on responding for nicotine and food under fixed-ratio and progressive ratio schedules of reinforcement in rats. Synapse, 50, pp. 20-28.
3. Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A. and Sved, A. F. (2001) Cue dependency of nicotine self-administration and smoking. Pharmacology Biochemistry and Behavior, 70, pp. 515-530.
4. Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A. and Sved, A. F. (2002) Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology, 163, pp. 230-237.
5. Caine, S. B., Lintz, R. and Koob, G. F. (1993) Intravenous drug self-administration techniques in animals. Behavioral neuroscience: A practical approach, pp. 93-115. Oxford University Press, New York
6. Cousins, M. S., Stamat, H. M. and de Wit, H. (2001) Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology, 157, pp. 243-253.
7. Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L. and Markou, A. (2003) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology, 168, pp. 347-358.
8. Damaj, M. I., Carroll, F. I., Eaton, J. B., Navarro, H. A., Blough, B. E., Mirza, S., Lukas, R. J. and Martin, B. R. (2004) Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotine receptors. Molecular Pharmacology, 66, pp. 675-682.
9. Donny, E. C., Caggiula, A. R., Mielke, M. M., Booth, S., Gharib, M. A., Hoffman, A., Maldovan, V., Shupenko, C. and McCallum, S. E. (1999) Nicotine self-administration in rats on a progressive-ratio schedule of reinforcement. Psychopharmacology, 147, pp. 135-142.
10. Donny, E. C., Caggiula, A. R., Rose, C., Jacobs, K. S., Mielke, M. M. and Sved, A. F. (2000) Differential effects of response-contingent and response-independent nicotine in rats. European Journal of Pharmacology, 402, pp. 231-240.
11. Donny, E. C., Chaudhri, N., Caggiula, A. R., Evans-Martin, F. F., Booth, S., Gharib, M. A., Clements, L. A. and Sved, A. F. (2003) Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: Implications for nicotine self-administration and reinforcement. Psychopharmacology, 169, pp. 68-76.
12. Epping-Jordan, M. P., Watkins, S. S., Koob, G. F. and Markou, A. (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature, 393, pp. 76-79.
13. Ferris, R. M., Cooper, B. R. and Maxwell, R. A. (1983) Studies of bupropion's mechanism of antidepressant activity. Journal of Clinical Psychiatry, 44, pp. 74-78.
14. Frenk, H. and Dar, R. (2004) Reward potentiation or behavioral activation? A comment on Donny et al. Psychopharmacology, 171, pp. 472-473.
15. Fryer, J. D. and Lukas, R. J. (1999) Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. Journal of Pharmacology and Experimental Therapeutics, 288, pp. 88-92.
16. Glick, S. D., Maisonneuve, I. M. and Kitchen, B. A. (2002) Antagonism of α3β4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. European Journal of Pharmacology, 438, pp. 99-105.
17. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., Watsky, E. J., Gong, J., Williams, K. E., Reeves, K. R. and Varenicline Phase 3 Study Group (2006) Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, pp. 47-55.
18. Harrison, A. A., Liem, Y. and Markou, A. (2001) Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology, 25, pp. 55-71.
19. Harrison, A. A., Gasparini, F. and Markou, A. (2002) Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY314582 or MPEP in rats. Psychopharmacology, 160, pp. 56-66.
20. Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M. and Svensson, T. H. (1997) Behavioral manifestations of the nicotine abstinence syndrome in the rat: Peripheral versus central mechanisms. Psychopharmacology, 129, pp. 348-356.
21. Hughes, J. R., Stead, L. F. and Lancaster, T. (1997) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews
22. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T. and Sullivan, P. M. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, pp. 1195-1202.
23. Huston-Lyons, D. and Kornetsky, C. (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacology Biochemistry and Behavior, 41, pp. 755-759.
24. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., Billing, C. B., Gong, J., Reeves, K. R. and Varenicline Phase 3 Study Group (2006) Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, pp. 56-63.
25. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C. and Baker, T. B. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, pp. 685-691.
26. Kenny, P. J. and Markou, A. (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacology Biochemistry and Behavior, 70, pp. 531-554.
27. Kenny, P. J. and Markou, A. (2006) Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31, pp. 1203-1211.
28. Kornetsky, C. and Esposito, R. U. (1979) Euphorigenic drugs: Effects on the reward pathways of the brain. Federation Proceedings, 38, pp. 2473-2476.
29. Li, S. X., Perry, K. W. and Wong, D. T. (2002) Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology, 42, pp. 181-190.
30. Maisonneuve, I. M. and Glick, S. D. (2003) Anti-addictive actions of an iboga alkaloid congener: A novel mechanism for a novel treatment. Pharmacology Biochemistry and Behavior, 75, pp. 607-618.
31. Malin, D. H., Lake, J. R., Schopen, C. K., Kirk, J. W., Sailer, E. E., Lawless, B. A., Upchurch, T. P., Shenoi, M. and Rajan, N. (1997) Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium. Pharmacology Biochemistry and Behavior, 58, pp. 695-699.
32. Malin, D. H., Lake, J. R., Smith, T. D., Khanbati, H. N., Meyers-Paul, R. L., Motellano, A. L., Jennings, R. E., Erwin, D. S., Presley, S. E. and Perales, B. A. (2005) Bupropion attenuates nicotine abstinence syndrome in the rat. Psychopharmacology, 184, pp. 494-503.
33. Mansvelder, H. D., Fagen, Z. M., Chang, B., Mitchum, R. and McGehee, D. S. (2007) Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area. Biochemical Pharmacology
34. Markou, A. and Koob, G. F. (1992) Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations. Physiology and Behavior, 51, pp. 111-119.
35. Markou, A. and Koob, G. F. (1993) Intracranial self-stimulation thresholds as a measure of reward. Behavioral neuroscience: A practical approach, pp. 93-115. Oxford University Press, New York
36. Markou, A. and Paterson, N. E. (2001) The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine & Tobacco Research, 3, pp. 361-373.
37. Miller, D. K., Sumithran, S. P. and Dwoskin, L. P. (2002) Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine. Journal of Pharmacology and Experimental Therapeutics, 302, pp. 1113-1122.
38. National Institutes of Health (1996) Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC
39. Nomikos, G. G., Damsma, G., Wenkstern, D. and Fibiger, H. C. (1989) Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology, 2, pp. 273-279.
40. Nomikos, G. G., Damsma, G., Wenkstern, D. and Fibiger, H. C. (1992) Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology, 7, pp. 7-14.
41. Olds, M. E. and Domino, E. F. (1969) Comparison of muscarinic and nicotinic cholinergic agonists on self-stimulation behavior. Journal of Pharmacology and Experimental Therapeutics, 166, pp. 189-204.
42. Palmatier, M. I., Evans-Martin, F. F., Hoffman, A., Caggiula, A. R., Chaudhri, N., Donny, E. C., Liu, X., Booth, S., Gharib, M., Craven, L. and Sved, A. F. (2006) Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers. Psychopharmacology, 184, pp. 391-400.
43. Panagis, G., Kastellakis, A., Spyraki, C. and Nomikos, G. (2000) Effects of methyllycaconitine (MLA), an α 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychopharmacology, 149, pp. 388-396.
44. Parrott, A. C. (1995) Stress modulation over the day in cigarette smokers. Addiction, 90, pp. 233-244.
45. Paterson, N. E., Balfour, D. J. K. and Markou, A. (2007) Chronic bupropion attenuated behavioral measures of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. European Journal of Neuroscience, 25, pp. 3099-3108.
46. Paterson, N. E. and Markou, A. (2004) Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology, 173, pp. 64-72.
47. Pellegrino, L. J., Pellegrino, A. S. and Cushman, A. J. (1979) A stereotaxic atlas of the rat brain, Plenum Press, New York
48. Rauhut, A. S., Dwoskin, L. P. and Bardo, M. T. (2005) Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. Nicotine & Tobacco Research, 7, pp. 901-907.
49. Rauhut, A. S., Neugebauer, N., Dwoskin, L. P. and Bardo, M. T. (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacology, 169, pp. 1-9.
50. Roddy, E. (2004) Bupropion and other non-nicotine pharmacotherapies. British Medical Journal, 328, pp. 509-511.
51. Rose, J. E., Behm, F. M. and Levin, E. D. (1993) Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacology Biochemistry and Behavior, 44, pp. 891-900.
52. Rukstalis, M., Jepson, C., Strasser, A., Lynch, K. G., Perkins, K., Patterson, F. and Lerman, C. (2005) Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology, 180, pp. 41-48.
53. Salas, R., Pieri, F. and De Biasi, M. (2004) Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit. Journal of Neuroscience, 24, pp. 10035-10039.
54. Shoaib, M., Sidhpura, N. and Shafait, S. (2003) Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology, 165, pp. 405-412.
55. Sidhpura, N., Redfern, P. and Wonnacott, S. (2007) Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices. European Journal of Pharmacology, 567, pp. 102-109.
56. Skjei, K. L. and Markou, A. (2003) Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology, 168, pp. 280-292.
57. Slemmer, J. E., Martin, B. R. and Damaj, M. I. (2000) Bupropion is a nicotinic antagonist. Journal of Pharmacol and Experimental Therapeutics, 295, pp. 321-327.
58. Suckow, R. F., Smith, T. M., Perumal, A. S. and Cooper, T. B. (1986) Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice and guinea pigs. Drug Metabolism and Disposition, 14, pp. 692-697.
59. Taylor, J. R. and Robbins, T. W. (1984) Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology, 84, pp. 405-412.
60. Taylor, J. R. and Robbins, T. W. (1986) 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology, 90, pp. 390-397.
61. Tella, S. R., Ladenheim, B. and Cadet, J. L. (1997) Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. Journal of Pharmacology and Experimental Therapeutics, 281, pp. 508-513.
62. Watkins, S. S., Stinus, L., Koob, G. F. and Markou, A. (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects. Journal of Pharmacology and Experimental Therapeutics, 292, pp. 1053-1064.
63. Welch, R. M., Lai, A. A. and Schroeder, D. H. (1987) Pharmacological significance of the species differences in bupropion metabolism. Xenobiotica, 17, pp. 287-298.
64. West, C. H. and Weiss, J. M. (1998) Effects of antidepressant drugs on rats bred for low activity in the swim test. Pharmacology Biochemistry and Behavior, 61, pp. 67-79.
65. Wiley, J. L., Lavecchia, K. L., Martin, B. R. and Damaj, M. I. (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Experimental and Clinical Psychopharmacology, 10, pp. 129-135.
66. Winer, B. J. (1971) Statistical principles in experimental design, McGraw-Hill, New York
67. Young, R. and Glennon, R. A. (2002) Nicotine and bupropion share a similar discriminative stimulus effect. European Journal of Pharmacology, 443, pp. 113-118.